Argan Inc (AGX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AGX Annual Cash Flow →
The quarterly cash flow data below helps track how Argan Inc's liquidity profile has evolved over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jul 31 2026)
6 Months
(Apr 30 2026) (Jan 31 2026) (Oct 31 2025) (Jul 31 2025)
Operating Activities
Income99.37
Depreciation & amortization1.20
Amortization of Other Assets0.15
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation4.46
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Increase Decrease In Contract With Customer Asset6.48
Operating Lease Right Of Use Asset Amortization Expense1.62
Increase Decrease In Contract With Customer Liability51.81
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable46.28
Increase (Decrease) in Accounts Payable and Accrued Liabilities41.05
Accrued Expense0.00
Increase (Decrease) in Billing in Excess of Cost of Earnings0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital13.69
Other Noncash Income (Expense)-0.31
Other net0.00
Payments for (Proceeds from) Other Operating Activities4.46
Discontinued operations0.00
Net Cash flow from Operating Activities210.35
Investing Activities
Capital Expenditures-7.69
Sale of Capital Items0.00
Short-term Investments Proceeds35.00
Short-term Investments Acq.-192.58
Real Estate Investments0.00
Payments To Fund Longterm Loans To Energy Project Developers-
Payments For Project Development Entities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross-7.97
Payments to Acquire Equity Method Investments0.00
Cash Divested from Deconsolidation0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net42.50
Discontinued operations0.00
Net Cash Flow from Investing Activities-130.74
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-9.65
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-28.06
Payments For Additional Loan To Related Party-
Cash Divested From Deconsolidation Of Variable Interest Entity-
Proceeds From Stock Options And Warrants Exercised-
Cash Distribution Payments To Joint Venture Partner-
Payments Of Distributions To Joint Venture Partners-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents339.48
Proceeds From Share Based Award Settlements Net Of Withholding Taxes Paid-23.69
Payments of Ordinary Dividends, Noncontrolling Interest0.00
Dividends paid-14.02
Net Cash Flow from Financing Activities-51.73
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow202.67
Total Cash Flow25.00
4 historic quarters locked

Sign in to unlock the full Argan Inc cash flow history.

About Argan Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-104745

Figures are derived from filed reports and may be restated. Historical data is subject to revision.